Elsevier

Public Health

Volume 119, Issue 9, September 2005, Pages 792-798
Public Health

Positive benefits of a pharmacist-managed hypertension clinic in Nigeria

https://doi.org/10.1016/j.puhe.2004.11.009Get rights and content

Summary

Objective

The aim of this study was to determine whether the provision of further practice-based support by pharmacists will bring about improved outcomes for blood pressure (BP) control in middle-aged and elderly Nigerian hypertensive patients managed with combination diuretics (amiloride hydrochloride 5 mg+hydrochlorothiazide 50 mg) and/or methyl dopa at the primary care level.

Design and setting

This was a 1-year prospective, randomized cohort study of the outpatients of a state comprehensive health centre in South-western Nigeria. Free primary health services including free drugs were provided for all patients.

Patients and method

The study population comprised 51 Nigerian patients with uncomplicated hypertension aged 45 years or more, with a 0.2–3.0-year history of hypertension, registered at the Comprehensive Health Centre, Ife between October 2002 and March 2003. They were invited into the pharmacist-managed hypertension clinic and followed for the study period. Participating pharmacists counselled for current medication, personalized goals of lifestyle modification stressing weight loss and/or increased activity, increased patient awareness by providing relevant education about hypertension and associated/related diseases, adjusted drug therapy to optimize effectiveness and minimize adverse events, utilized treatment schedules that enhanced patients' adherence to therapy, and monitored treatment outcomes between enrolment and return visits. Patient satisfaction and the number of treatment failures within 6 months post enrolment were compared with retrospective data from our earlier study involving physician-managed patients under a similar setting.

Results

Uncontrolled BP reduced from 92 to 36.2% by 10.15±5.02 days after enrolment. Treatment failures were observed at 5.9% of the total return visits (n=184) within 6 months.

Conclusion

Pharmacist-managed hypertension clinics can improve BP control, reduce treatment failure and increase patient satisfaction.

Introduction

A large proportion of hypertensive patients in Nigeria live with untreated or uncontrolled blood pressure (BP), although reductions in elevated BP have been shown to reduce the risk of cardiovascular mortality and morbidity.1 While there is considerable evidence for the benefit of drug treatment in reducing BP,2 published guidelines for the management of hypertensive patients recommend that strategies should be implemented at the primary care level.3, 4 Pharmacy-based programmes are cost effective, can be used to determine the ideal drug and when/how it should be used, and can provide ancillary programmes to support appropriate physician prescribing and optimal patient adherence.5

A recent investigation into BP control in hypertensive Nigerian blacks managed with alpha methyldopa and combination diuretics at the primary care level6 revealed a treatment gap; only 37.5% of the studied patients had controlled BP after their first treatment, and 10.2 and 4% of the study population needed three and five treatments within 6 months, respectively, to achieve target BP levels. In nearly all cases, diuretic therapy was not individualized and lifestyle modification was not prioritized.6 A pharmacist-managed hypertension clinic was therefore set up in the facility as an intervention. We report the benefits of the provision of additional practice-based support by pharmacists at the health centre facility on BP control in this low-income population. This is the first report on this topic in Nigeria.

Section snippets

Methods

This was a 1-year prospective, randomized cohort study of the outpatients of a state comprehensive health centre in South-western Nigeria. Free primary health services including free drugs were provided for all patients. The study population comprised 51 Nigerian patients with uncomplicated hypertension aged 45 years or more, with a 0.2–3-year history of hypertension, registered at the Comprehensive Health Centre, Ife between October 2002 and March 2003. They were invited into the

Results

Fifty-one patients were enrolled in the study; 15 males and 36 females. Of these, 33.3, 43.1 and 19.6% were normal weight, overweight and obese, respectively, and only 3.9% suffered from extreme obesity at enrolment according to ‘Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: the Evidence Report’.8 The patients were either non-alcohol drinkers or did so at a frequency and volume that was considered to be inconsequential.10 About 63%

Discussion

Supposition from the retrospective study of Erhun et al.6 showed that hypertensive Nigerian blacks ignore routine check ups and seldom go to clinic except when highly inconvenienced by the disease. This may explain the high level of unchecked BP in patients managed by physicians at the health centre during the years covered by the retrospective study,6 and it perhaps explains why a number of the patients enrolled into this study did not attend again after at least one normal BP reading (Fig. 1)

Conclusion

The pharmaceutical service provided by a pharmacist-managed hypertension clinic improved BP control, reduced treatment failures and recorded remarkable patient satisfaction. The impact of this intervention on clinical outcomes such as mortality and morbidity will be the focus of further studies.

Acknowledgements

The authors acknowledge the support of the Medical Officer and clinic staff of the Comprehensive Health Centre, Sabo, Ile-Ife as well as the support of the Hospital Management Board, Osogbo, Osun State, Nigeria.

References (27)

  • R. Collins et al.

    Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in epidemiological context

    Lancet

    (1990)
  • L.E. Ramsay et al.

    British hypertension society guidelines for hypertension management : summary

    BMJ

    (1999)
  • Health Survey for England

    (1998)
  • Scottish Health Statistics 2000. Web resource. Edinburgh....
  • D.A. Sclar

    Disease state management: an overview for the managed care pharmacist

    Drug Benefit Trends

    (1996)
  • W.O. Erhun et al.

    Managing hypertension with combination diuretics and methyldopa in Nigerian blacks at the primary care level

    Clin Drug Invest

    (2003)
  • The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood...
  • National Heart Lung and Blood Institute (NHLBI) obesity education imitative: Clinical Guidelines on the Identification,...
  • Medical Research Council trial of treatment of hypertension in older adults: principal results

    BMJ

    (1992)
  • A.L. Klatsky et al.

    Alcohol consumption and blood pressure

    N Engl J Med

    (1977)
  • M.P. Okamoto et al.

    Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic

    Pharmacotherapy

    (2001)
  • J.M. McKenney et al.

    The effect of clinical pharmacy services on patients with essential hypertension

    Circulation

    (1973)
  • P.J. Schneider et al.

    Role effectiveness of a pharmacist in the maintenance of patients with hypertension and congestive heart failure

    Contemp Pharm Pract

    (1982)
  • Cited by (35)

    View all citing articles on Scopus
    View full text